Whales with a lot of money to spend have taken a noticeably bearish stance on Johnson & Johnson.
Looking at options history for Johnson & Johnson JNJ we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $1,337,900 and 2, calls, for a total amount of $123,232.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $145.0 to $160.0 for Johnson & Johnson during the past quarter.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Johnson & Johnson options trades today is 3709.43 with a total volume of 4,332.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Johnson & Johnson’s big money trades within a strike price range of $145.0 to $160.0 over the last 30 days.
Johnson & Johnson 30-Day Option Volume & Interest Snapshot
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | PUT | TRADE | BEARISH | 07/18/25 | $10.5 | $9.85 | $10.25 | $160.00 | $809.7K | 4.0K | 790 |
| JNJ | PUT | TRADE | BEARISH | 07/18/25 | $3.25 | $3.05 | $3.25 | $150.00 | $256.7K | 6.3K | 822 |
| JNJ | CALL | SWEEP | BULLISH | 09/19/25 | $8.95 | $8.9 | $8.95 | $145.00 | $80.5K | 2.1K | 90 |
| JNJ | PUT | SWEEP | BEARISH | 07/18/25 | $10.9 | $10.5 | $10.9 | $160.00 | $73.0K | 4.0K | 1.1K |
| JNJ | PUT | TRADE | BULLISH | 07/18/25 | $6.7 | $6.55 | $6.55 | $155.00 | $65.5K | 4.1K | 130 |
About Johnson & Johnson
Johnson & Johnson is the world’s largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company’s sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
In light of the recent options history for Johnson & Johnson, it’s now appropriate to focus on the company itself. We aim to explore its current performance.
Current Position of Johnson & Johnson
- Trading volume stands at 4,769,606, with JNJ’s price down by -0.69%, positioned at $149.69.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 26 days.
Expert Opinions on Johnson & Johnson
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $181.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
* An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $181.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.